AbbVie Inc. News Headlines

ABBV 
$58.24
*  
0.59
1.02%
Get ABBV Alerts
*Delayed - data as of Mar. 30, 2015  -  Find a broker to begin trading ABBV now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By





Is the Pharmacyclics–AbbVie Merger a Setup?
3/30/2015 9:06:00 AM - Market Realist










Is Antitrust a Risk in the Life Time Fitness Merger?
3/27/2015 4:06:00 PM - Market Realist


Life Time Fitness: An Activity for Everyone
3/27/2015 12:06:00 PM - Market Realist




Transaction Basics of the Life Time Fitness Merger
3/26/2015 6:06:00 PM - Market Realist


How Gilead And AbbVie Closed The HCV Door On Merck
3/25/2015 3:29:00 PM - Seeking Alpha


Read This Before You Sell Gilead Sciences
3/25/2015 12:01:00 PM - Investopedia






Could the Pharmacyclics–AbbVie Merger Get Competitive?
3/24/2015 12:06:00 PM - Market Realist






Why My Price Target Has Increased In Biogen
3/23/2015 5:33:00 PM - Seeking Alpha








Rationale for the Pharmacyclics–AbbVie Merger
3/23/2015 10:06:00 AM - Market Realist